Compounds > gadolinium dtpa
Page last updated: 2024-09-04

gadolinium dtpa and 1-methylpropyl-2-imidazolyl disulfide

gadolinium dtpa has been researched along with 1-methylpropyl-2-imidazolyl disulfide in 1 studies

Compound Research Comparison

Studies
(gadolinium dtpa)		Trials
(gadolinium dtpa)		Recent Studies (post-2010)
(gadolinium dtpa)		Studies
(1-methylpropyl-2-imidazolyl disulfide)		Trials
(1-methylpropyl-2-imidazolyl disulfide)		Recent Studies (post-2010) (1-methylpropyl-2-imidazolyl disulfide)
12,6546644,05161546

Protein Interaction Comparison

ProteinTaxonomygadolinium dtpa (IC50)1-methylpropyl-2-imidazolyl disulfide (IC50)
Replicase polyprotein 1abBetacoronavirus England 17.6
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 20.14
ThioredoxinHomo sapiens (human)2.11

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baker, AF; Gillies, RJ; Jordan, BF; Powis, G; Raghunand, N; Runquist, M; Tate, WR1

Other Studies

1 other study(ies) available for gadolinium dtpa and 1-methylpropyl-2-imidazolyl disulfide

ArticleYear
The thioredoxin-1 inhibitor 1-methylpropyl 2-imidazolyl disulfide (PX-12) decreases vascular permeability in tumor xenografts monitored by dynamic contrast enhanced magnetic resonance imaging.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Jan-15, Volume: 11, Issue:2 Pt 1

    Topics: Albumins; Animals; Capillary Permeability; Colonic Neoplasms; Contrast Media; Disulfides; Female; Gadolinium DTPA; Humans; Imidazoles; Magnetic Resonance Imaging; Mice; Mice, SCID; Oxidation-Reduction; Thioredoxins; Vascular Endothelial Growth Factor A

2005